FelixTM: Viewpoint from Japan
As the first major global commercial agreement to sell and distribute the FelixTM sperm separation device goes from…
Memphasys accelerates commercial approval for sperm-separation device
Memphasys recently signed an exclusive distribution agreement with Vitrolife Japan KK, a subsidiary of the Vitrolife…
Why FelixTM is big in Japan
Memphasys recently signed an exclusive distribution agreement with Vitrolife Japan KK, a subsidiary of the Vitrolife…
Fantastic Austrade support for Felix in Japan
Memphasys recently signed an exclusive distribution agreement with Vitrolife Japan KK, a subsidiary of the Vitrolife…
Watch: Understanding male fertility
Laureate Professor John Aitken, Scientific Director at Memphasys, and Professor Robert McLachlan, Endocrinologist and…
As crisis in human fertility looms, Australian innovator creates revolution in IVF tech
Modern life means average family sizes are falling and, with less selection pressure on high fertility genes, more…
What is happening to the human male?
Something strange is happening to the human male. The incidence of testicular germ cell tumours is increasingly…
Better Technology, More Life: Memphasys’ Commitment to Advancing Reproductive Biotechnology
At Memphasys, our unwavering purpose is encapsulated in four simple but powerful words: better technology, more life.…
New Japanese partnership joins the Memphasys revolution in IVF sperm separation technology
Meet Marcus Hedenskog. Lead Memphasys APAC partner and key contributor to the breakthrough commercialisation of the…
Revolutionising Reproductive Medicine: Dr. Ramya Jayaram to Present Groundbreaking ICSI Research at ASPIRE 2023
We are thrilled that Dr. Ramya Jayaram from Women's Center and Hospitals in Coimbatore, India, will be presenting at…